TBPH Competitors & Alternatives
Compare Theravance Biopharma Inc with similar stocks in the same industry
Biotechnology
TBPH
Main Stock$16.32
Tradestie Score
60
Market Cap
$726.21M
P/E Ratio
7.4
Revenue Growth
0.2%
Analyst Upside
+6.6%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$10.71
|
$871.90M | - | 55 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$8.23
|
$868.46M | - | 54 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$5.97
|
$867.49M | - | 52 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$16.63
|
$864.42M | - | 59 | Compare |
|
CRMD
CorMedix Inc.
|
$8.59
|
$862.55M | 4.1 | 66 | Compare |
|
SEPN
Septerna, Inc. Common Stock
|
$36.03
|
$847.12M | - | 59 | Compare |
|
XNCR
Xencor, Inc.
|
$12.21
|
$843.75M | - | 55 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$20.37
|
$841.74M | - | 51 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$34.06
|
$832.47M | - | 57 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$30.87
|
$824.20M | - | 60 | Compare |
More TBPH Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry